CASI Pharmaceuticals, Inc. (CASI)
$0.15+7.14%Close
SELLCRISIS · day 28
Key stats
- Market cap
- $2M
- Beta
- 0.89
- P/E (TTM)
- -0.10
- 1W
- -28.57%
- 1M
- -80.00%
- vs SPY 1W
- -29.73%
- vs SPY 1M
- -82.99%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on CASI?
- LOPJLB’s latest quantitative signal on CASI Pharmaceuticals, Inc. (CASI) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is CASI in?
- CASI Pharmaceuticals, Inc. (CASI) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does CASI Pharmaceuticals, Inc. (CASI) do?
- CASI Pharmaceuticals, Inc. is a biopharmaceutical firm focused on the development and market introduction of medical treatments and drugs across China, the United States, and globally. Its marketed product, EVOMELA, is an intravenous formulation of melphalan, utilized for conditioning prior to stem cell transplantation and as a palliative option for patients suffering from multiple myeloma. The…